The current study demonstrated that compared with patients with CRP/Alb ratio ≤0.089, those with CRP/Alb ratio >0.089 had approximately three-fold higher risk for recurrence and death after hepatic resection for ICC. The gene discussed is CRP; the disease is intrahepatic cholangiocarcinoma.